15.05.2014 Views

CHAPTER 3 Tumours of the Stomach - Pathology Outlines

CHAPTER 3 Tumours of the Stomach - Pathology Outlines

CHAPTER 3 Tumours of the Stomach - Pathology Outlines

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Fig. 3.14 Undifferentiated gastric carcinoma.<br />

Fig. 3.15 Hepatoid variant <strong>of</strong> gastric carcinoma.<br />

Fig. 3.16 Gastric choriocarcinoma composed <strong>of</strong> syncytiotrophoblastic and cytotrophoblastic cells next to<br />

thin-walled vascular structures. A Papillary carcinoma component is adjacent to <strong>the</strong> choriocarcinoma.<br />

B High magnification <strong>of</strong> <strong>the</strong> choriocarcinoma.<br />

B<br />

or no gland formation. The cells usually<br />

appear round and small, ei<strong>the</strong>r arranged<br />

as single cells or clustered in abortive,<br />

lacy gland-like or reticular formations.<br />

These tumours resemble those classified<br />

as signet-ring cell tumours in <strong>the</strong> WHO<br />

classification. The mitotic rate is lower in<br />

diffuse carcinomas than in intestinal<br />

tumours. Small amounts <strong>of</strong> interstitial<br />

mucin may be present. Desmoplasia is<br />

more pronounced and associated inflammation<br />

is less evident in diffuse cancers<br />

than in <strong>the</strong> intestinal carcinomas.<br />

Rare variants<br />

Several o<strong>the</strong>r carcinomas exist that are<br />

not an integral part <strong>of</strong> <strong>the</strong> Laurén or WHO<br />

classifications.<br />

Adenosquamous carcinoma<br />

This lesion combines an adenocarcinoma<br />

and squamous cell carcinoma; nei<strong>the</strong>r<br />

quantitatively prevails. Transitions<br />

exist between both components. A<br />

tumour with a distinct boundary between<br />

<strong>the</strong> two components may represent a<br />

collision tumour. <strong>Tumours</strong> containing discrete<br />

foci <strong>of</strong> benign-appearing squamous<br />

metaplasia are termed adenocarcinomas<br />

with squamous differentiation<br />

(synonymous with adenoacanthoma).<br />

Squamous cell carcinoma<br />

Pure squamous cell carcinomas develop<br />

rarely in <strong>the</strong> stomach; <strong>the</strong>y resemble<br />

squamous cell carcinomas arising elsewhere<br />

in <strong>the</strong> body.<br />

Undifferentiated carcinoma<br />

These lesions lack any differentiated features<br />

beyond an epi<strong>the</strong>lial phenotype<br />

(e.g. cytokeratin expression). They fall<br />

into <strong>the</strong> indeterminate group <strong>of</strong> Laurén’s<br />

scheme. Fur<strong>the</strong>r analysis <strong>of</strong> this heterogeneous<br />

group using histochemical methods<br />

may allow <strong>the</strong>ir separation into o<strong>the</strong>r<br />

types.<br />

O<strong>the</strong>r rare tumours include mixed adenocarcinoma-carcinoid<br />

(mixed exocrineendocrine<br />

carcinoma), small cell<br />

carcinoma, parietal cell carcinoma, choriocarcinoma,<br />

endodermal sinus tumour,<br />

embryonal carcinoma, Paneth cell richadenocarcinoma<br />

and hepatoid adenocarcinoma.<br />

A<br />

Fig. 3.17 A, B Adenocarcinoma, poorly differentiated. These two lesions show both intestinal and diffuse<br />

components (Laurén classification).<br />

B<br />

Early gastric cancer<br />

Early gastric cancer (EGC) is a carcinoma<br />

limited to <strong>the</strong> mucosa or <strong>the</strong> mucosa<br />

and submucosa, regardless <strong>of</strong> nodal status.<br />

Countries in which asymptomatic<br />

patients are screened have a high incidence<br />

<strong>of</strong> EGCs ranging from 30-50%<br />

{1410, 908, 718}, contrasting with a<br />

smaller fraction <strong>of</strong> 16-24% {620, 253,<br />

627} in Western countries. The follow-up<br />

<strong>of</strong> dysplastic lesions does appear to<br />

increase <strong>the</strong> prevalence <strong>of</strong> EGC. The<br />

cost effectiveness <strong>of</strong> such an integrated<br />

Gastric carcinoma<br />

45

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!